经皮经导管射频消融去肾交感神经术在难治性高血压中的应用
摘要
高血压已经成为全球性公共健康问题之一。据统计,全世界大约有25%的人口,近10亿人为高血压患者,预计到2025年,这个数字将增长至15亿[1]。目前高血压的治疗主要是生活方式干预和药物治疗,但血压控制情况不容乐观。研究表明,尽管使用充分的药物治疗,仍有将近一半的美国高血压患者未达到血压控制目标[2]。难治性高血压是指使用包含利尿剂在内的3种或以上足量降压药物仍难以达到血压目标值,
出处
《中华高血压杂志》
CAS
CSCD
北大核心
2013年第5期424-427,共4页
Chinese Journal of Hypertension
基金
国家自然基金重点项目(81130010)
江苏省自然科学基金(BK2011603)
东南大学创新基金(seucx201107)
参考文献31
-
1Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data[J]. Lancet, 2005,365 (9455) :217 223.
-
2Lloyd Jones D, Adam stroke statistics 2010 s RJ, Brown TM, et al. Heart disease and update: a report from the American HeartAssociation[J] Circulation,2010,121(?) :e46 e215.
-
3卢新政,陈秀梅.顽固性高血压[J].中华高血压杂志,2008,16(9):858-862. 被引量:12
-
4Moser M, Setaro JF. Clinical practice. Resistant or difficult to control hypertension[J]. N Engl J Med,2006,355(4):385 392.
-
5Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure[J] Hypertension, 2003,42 (6) :1206-1252.
-
6Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommit- tee[J]. Circulation, 2009,119(3) : 480-486.
-
7DiBona GF, Kopp UC. Neural control of renal function[J]. Physiol Rev,1997,77(1) :75-197.
-
8Katholi RE. Renal nerves in the pathogenesis of hypertension in experimental animals and humans[J]. Am J Physiol, 1983,245 (1) :F1-F14.
-
9Goldstein DS. Plasma catecholamines and essential hypertension: an analytical review[J]. Hypertension, 1983,5 ( 1 ) : 86-99.
-
10Esler M, Jennings G, Biviano B, et al. Mechanism of elevated plasma noradrenaline in the course of essential hypertension[J]. J Cardiovasc Pharmacol,1986,8(Suppl 5) :$39-43.
二级参考文献13
-
1Calhoun DA, Jones D, Textor S, et al. Resistant hypertension:diagnosis, evaluation and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension, 2008, 51 : 1403-1419.
-
2Krum H, Sobotka P, Mahfoud F, et al. Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation, 2011,123 : 209-221.
-
3Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof -of -principle cohort study. Lancet, 2009,373 : 1275-1281.
-
4Schlaich MP, Sobotka PA, Krum H, et al. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med, 2009, 361 : 932-934.
-
5Symplicity HTN-1 investigators. Catheter-based renal sympathetic denervation for resistant hyptersion: durability of blood pressure reduction out to 24 months. Hypertension, 2011,57:911-917.
-
6Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension ( The Symplicity HTN-2 Trial) : a randomised controlled trial. Lancet, 2010,376 : 1903-1909.
-
7Prochnau D, Lauten A, Busch M, et al. Catheter-based radiofrequency ablation therapy of the renal sympathetic-nerve system for drug resistant hypertension in a patient with end-stage renal disease. Int J Cardiol,2012,154 : e29-30.
-
8Ukena C, Mahfoud F, Kindermann I, et al. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol, 2011,58: 1176- 1182.
-
9Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 1999, 130: 461-470.
-
10Schlaich MP, Lambert E, Kaye DM, et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension, 2004, 43 : 169-175.
共引文献26
-
1王祁民.80岁以上老年高血压患者降压治疗体会[J].中国医师进修杂志,2011,34(S01):110-111.
-
2钱静,伍伟锋,刘唐威.正确识别难治性高血压[J].中华高血压杂志,2009,17(8):684-686. 被引量:1
-
3赵汝宁,唐荣德,周振强,赵柏庆.安体舒通联合麝香保心丸治疗顽固性高血压临床观察[J].中西医结合心脑血管病杂志,2011,9(2):133-135. 被引量:5
-
4周艳芳,方会龙,王俊杰.顽固性高血压56例临床治疗体会[J].现代医药卫生,2011,27(5):698-698. 被引量:1
-
5吴胜国.顽固性高血压的诊断与治疗探讨[J].中国卫生产业,2011,8(5):116-116.
-
6李莹,徐克雷.高血压治疗的研究进展与展望[J].实用心脑肺血管病杂志,2013,21(8):1-4. 被引量:20
-
7刘焱,董烨.经导管射频消融肾交感神经术治疗难治性高血压的护理[J].护士进修杂志,2013,28(19):1752-1754. 被引量:6
-
8蒋雄京,董徽.经皮经导管去肾神经术治疗难治性高血压的临床规范[J].心血管病学进展,2013,34(6):719-722.
-
9卢成志,张瑾.经导管去肾交感神经术——当前各种技术的优劣比较[J].心血管病学进展,2013,34(6):722-725. 被引量:2
-
10马琳琳,余振球,屈丰雪,何蕾.顽固性高血压合并糖代谢异常患者动态血压变化分析[J].中国医药,2014,9(1):1-5. 被引量:5
-
1陆菊明.糖尿病血压目标值:并非越低越好[J].中华医学信息导报,2011,26(19):8-8.
-
2谢扬,饶邦复.高血压新知(三)[J].现代医药卫生,2007,23(2):203-204.
-
3王宁,秦明照.糖尿病患者血压控制目标的争论[J].心血管病学进展,2014,35(2):153-156. 被引量:1
-
4邓立新.高血压合并糖尿病的治疗研究[J].中国热带医学,2007,7(11):2120-2122. 被引量:13
-
5曼西亚,廖宇.糖尿病和非糖尿病人群的降压治疗和血压控制目标[J].糖尿病天地(临床),2012(8):360-363.
-
6高振东.卡托普利与氢氯噻嗪联用治疗原发性高血压疗效观察[J].中国乡村医药,2007,14(4):14-14. 被引量:4
-
7金世兰.高血压合并糖尿病患者的降压目标及治疗[J].医学与哲学(B),2008,29(1):32-33. 被引量:9
-
8蒋雄京.高血压(4)高血压与冠心病(续3)[J].中国循环杂志,2012,27(3):168-169. 被引量:16
-
9肖祥云.老人降血压 达标别超标[J].家庭中医药,2007,14(1):32-32.
-
10马玉良,孙宁玲.糖尿病病人中的降压治疗[J].心血管病学进展,2004,25(2):111-115. 被引量:5